AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
24/7 Wall St. on MSN4d
AbbVie Just Paid Investors: Here’s How Much They ReceivedAbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb.
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie ...
AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to ...
AbbVie Inc. (NYSE:ABBV – Get Free Report) was the target of unusually large options trading activity on Monday. Stock ...
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback